Insultrate
Commercial- Indications
- Diabetes
Company intelligence / Profile preview
Health2Sync’s digital therapeutics and data-driven care platform have demonstrated improved outcomes in real-world settings for diabetes patients—such as better HbA1c/glucose control and increased healthcare efficiency. The company has expanded its offerings to include CGM integration with Abbott devices and AI-powered patient engagement programs. It collaborates with major pharma companies to integrate smart insulin pens and other connected devices into its ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health2Sync.